Alpelisib-Is the Piqray India version genuine?

Alpelisib (Alpelisib)-Piqray India is a genuine drug. It is an Indian original drug and is produced byNovartis Ltd/Swiss Novartis Pharmaceuticals. The difference between it and the European versionAlpelisib original drug may be different packaging, different specifications, etc. The price of the drug may be different in different regions, but the drug ingredients are consistent. There is currently no Indian version of the generic version of Apelvis produced and marketed.

Apelvis is a targeted (biological) therapy that interferes with processes in cells that help cancer grow, and belongs to a group of drugs called PI3K (phosphatidylinositol-3-kinase) inhibitors. Apelvis is used to treat estrogen receptor-positive and HER2-negative breast cancer with changes (mutations) in a gene called PIK3CA. It is used with the hormone treatment drug fulvestrant. If a patient's breast cancer has a PIK3CA gene mutation and has received hormone therapy for breast cancer and a CDK 4/6 inhibitor (such as abemaciclib, palbociclib, or ribociclib), they may be treated with apelvis.

The original drug of Apellis is not marketed in the country and therefore cannot be included in medical insurance. The European version of Apelvis Original drug, specifications150mg*56 tablets sold overseas may cost more than 4 RMB 4 per box (the price may fluctuate due to the exchange rate), The specifications of the Indian versionThe price of each box of 150mg*28 tablets may be more than 5,000 yuan (the price may fluctuate due to the exchange rate). For specific price and drug information of Apelvis, please consult Yaode Medical Consultant.